GTBPNasdaq CM

GT Biopharma, Inc.

0.30−2.06%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock GTBP to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+8.98%, upReturn · 1w
−10.27%, downReturn · 1m
−24.13%, downReturn · 3m
−72.50%, downReturn · 1y
−78.12%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 44.

RSI (14)43.77, caution readingLower-neutral
MACD / signal-0.02 / -0.02, favorable readingAbove signal line
SMA 500.37, caution readingPrice below
SMA 2000.50, caution readingPrice below
EMA 200.31, caution readingPrice below
ADX (14)34.32Trending
+DI / −DI15.40 / 19.93, caution reading−DI leading
ATR (14)0.02, flagged reading6.4% of price — elevated daily swings
Stochastic %K46.52Mid-range
Bollinger bands (20)0.27 – 0.33Inside bands
ROC (10)-4.25, caution readingNegative over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking GTBP reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock GTBP: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get GTBP + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock GTBP